Altered Interleukin-6 Receptor, IL-6R and gp130, Production and Expression and Decreased SOCS-3 Expression in Placentas from Women with Pre-eclampsia

Placenta

Volumn 29, Issue 12, 2008, Pages 1024-1028

  Zhao, S ^a   Gu, Y ^a   Dong, Q ^a   Fan, R ^a   Wang, Y ^a,b  

^a Louisiana State University School of Medicine Shreveport   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

gp130; Interleukin 6R; Placenta; Pre eclampsia; SOCS 3

Indexed keywords

GLYCOPROTEIN GP 130; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; PLACENTA; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; WESTERN BLOTTING;

ADULT; BLOTTING, WESTERN; CHORIONIC VILLI; CYTOKINE RECEPTOR GP130; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; YOUNG ADULT;

EID: 56249139690     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2008.09.011     Document Type: Article

References (25)

1. Taga T., and Kishimoto T. Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 15 (1997) 797-819
2. Jones S.A. Directing transition from innate to acquired immunity: defining a role for IL-6. J Immunol 175 (2005) 3463-3468
3. Diehl S., and Rincón M. The two faces of IL-6 on Th1/Th2 differentiation. Mol Immunol 39 (2002) 531-536
4. Kubo M., and Inoue H. Suppressor of cytokine signaling 3 (SOCS3) in Th2 cells evokes Th2 cytokines, IgE, and eosinophilia. Curr Allergy Asthma Rep 6 (2006) 32-39
5. Croker B.A., Krebs D.L., Zhang J.G., Wormald S., Willson T.A., Stanley E.G., et al. SOCS3 negatively regulates IL-6 signaling in vivo. Nat Immunol 4 (2003) 540-545
6. Jones S.A., Richards P.J., Scheller J., and Rose-John S. IL-6 transsignaling: the in vivo consequences. J Interferon Cytokine Res 25 (2005) 241-253
7. Gaillard J., Pugnière M., Tresca J., Mani J., Klein B., and Brochier J. Interleukin-6 receptor signaling. II. Bio-availability of interleukin-6 in serum. Eur Cytokine Netw 10 (1999) 337-344
8. Knüpfer H., and Preiss R. sIL-6R: more than an agonist?. Immunol Cell Biol 86 (2008) 87-91
9. Jostock T., Müllberg J., Ozbek S., Atreya R., Blinn G., Voltz N., et al. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses. Eur J Biochem 268 (2001) 160-167
10. Wang Y., and Walsh S.W. TNFα concentrations and mRNA expression are increased in preeclamptic placentas. J Reprod Immunol 32 (1996) 157-169
11. Bowen R.S., Gu Y., Zhang Y., Lewis D.F., and Wang Y. Hypoxia promotes interleukin-6 and -8 but reduces interleukin-10 production by placental trophoblast cells from preeclamptic pregnancies. J Soc Gynecol Invest 12 (2005) 428-432
12. Meisser A., Cameo P., Islami D., Campana A., and Bischof P. Effects of interleukin-6 (IL-6) on cytotrophoblastic cells. Mol Hum Reprod 5 (1999) 1055-1058
13. Kharfi A., Giguère Y., Sapin V., Massé J., Dastugue B., and Forest J.C. Trophoblastic remodeling in normal and preeclamptic pregnancies: implication of cytokines. Clin Biochem 36 (2003) 323-331
14. Kauma S.W., Wang Y., and Walsh S.W. Preeclampsia is associated with decreased placental interleukin-6 production. J Soc Gynecol Investig 2 (1995) 614-617
15. Kauma S.W., Herman K., Wang Y., and Walsh S.W. Differential mRNA expression and production of interleukin-6 in placental trophoblast and villous core compartments. Am J Reprod Immunol 30 (1994) 131-135
16. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists, Number 23, January 2002. Practice Bulletins Volume II (2007) 640-648
17. Wang Y., Adair C.D., Weeks J.W., Lewis D.F., and Alexander J.S. Increased neutrophil-endothelial adhesion induced by placental factors is mediated by platelet-activating factor in preeclampsia. J Soc Gynecol Invest 6 (1999) 136-141
18. Li H., Gu B., Zhang Y., Lewis D.F., and Wang Y. Hypoxia-induced increase in soluble Flt-1 production correlates with enhanced oxidative stress in trophoblast cells from the human placenta. Placenta 25 (2005) 210-217
19. Zhao S., Gu Y., Lewis D.F., and Wang Y. Predominant basal directional release of thromboxane, but not prostacyclin, by placental trophoblasts from normal and preeclamptic pregnancies. Placenta 29 (2008) 81-88
20. Peters M., Müller A.M., and Rose-John S. Interleukin-6 and soluble interleukin-6 receptor: direct stimulation of gp130 and hematopoiesis. Blood 92 (1998) 3495-3450
21. Krebs D.L., and Hilton D.J. SOCS proteins: negative regulators of cytokine signaling. Stem Cells 19 (2001) 378-387
22. Roberts A.W., Robb L., Rakar S., Hartley L., Cluse L., Nicola N.A., et al. Placental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3. Proc Natl Acad Sci USA 98 (2001) 9324-9329
23. Lang R., Pauleau A.L., Parganas E., Takahashi Y., Mages J., Ihle J.N., et al. SOCS3 regulates the plasticity of gp130 signaling. Nat Immunol 4 (2003) 546-550
24. Leisser C., Saleh L., Haider S., Husslein H., Sonderegger S., and Knöfler M. Tumour necrosis factor-alpha impairs chorionic gonadotrophin beta-subunit expression and cell fusion of human villous cytotrophoblast. Mol Hum Reprod 12 (2006) 601-609
25. Caniggia I., Grisaru-Gravnosky S., Kuliszewsky M., Post M., and Lye S.J. Inhibition of TGF-beta 3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies. J Clin Invest 103 (1999) 1641-1650